Ralph Stone, PhD

CTO, EternaTear

As CTO of EternaTear, Dr. Stone focuses on achieving formulation, clinical, and regulatory milestone. Most recently, Ralph was the VP of Consumer R&D at Alcon where he developed and launched much of the Systane® artificial tear product line. A PhD chemist by training, Ralph has 35 years of ophthalmic R&D experience and is a recognized FDA expert in the field of ophthalmology.

MED1 Ventures LLC.

Raleigh, NC
San Francisco, CA
Shanghai, China
Leopoldshafen, Germany

Call 919.241.3200
Email [email protected]

Follow Us